SION

Conviction 65HealthcareScan · Mon, Aug 10, 2026

Evening star

SION$4.50-91.18%

ResistanceSupportVol 14Insider sell

Vol MA14 2.77M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Sionna Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.sionnatx.com ↗

Price4.50

Change-91.18%

Gap-90.43%

Rel volume50.28×

Avg volume2.16M

Avg $ vol35.31M

SMA 2044.59

SMA 5041.67

SMA 20040.08

Price vs 50-89.20%

Price vs 200-88.77%

MA stackmixed

50/200 cross—

Supertrenddown · 28.63

RSI (14)19

MACD hist-2.67

MACD crossbear · 0d

Stoch %K / %D1 / 47

ADX (14)34

+DI / −DI12 / 53

RSI divergence—

MACD divergenceBearish

ATR %+148.66%

ADR %8.82%

52w high51.04

52w low4.50

From 52w high-91.18%

Above 52w low+0.00%

New 52w highNo

SqueezeFired

Bollinger width84.76%

%B-0.56

Donchian pos0.96%

Donchian high54.97

Donchian low4.01

AVWAP (52w high)5.60

vs AVWAP high-19.69%

AVWAP (52w low)4.50

vs AVWAP low+0.00%

OBV trendDown

Chaikin MF (20)-0.02

Today vs 20d50.28×

Avg vol (14d)2.77M

Avg vol (20d)2.16M

Avg $ vol (20d)35.31M

Market cap—

RS 3m (vs SPY)+12.15%

RS 6m (vs SPY)+30.68%

RS line new highNo

Trend template2/8

Technical rank0.4

1 week-90.86%

1 month-90.06%

3 months-89.83%

6 months-87.54%

1 year-73.96%

YTD-88.52%

P/E-30.66

P/B8.68

P/S—

P/FCF-34.61

EPS-1.88

Div yield—

ROE-28.32%

ROA-26.57%

Debt/Eq—

Current20.05

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-22.01%

Price target53.14

Target upside4.12%

Analyst ratingBuy

Institutional103.92%

Ent. value2.24B

Revenue—

Net income-29.89M

Gross profit—

Free cash flow-66.67M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out45.15M

Employees59

ListedFri, Feb 7, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank0.4 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmEvening star

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SION

All disclosures →

No recent disclosed trades by Congress in SION. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SION · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
ORBIMED ADVISORS LLC Director · Common Stock · 2026-07-07	Sell	85.92K	$3.9M	2026-07-07	2026-07-09
Thompson Peter A. Director · Common Stock · 2026-07-07	Sell	85.92K	$3.9M	2026-07-07	2026-07-09
Fitzpatrick Jennifer Chief Legal Officer · Common Stock · 2026-07-06	Exercise	10.25K	$63K	2026-07-06	2026-07-07
Fitzpatrick Jennifer Chief Legal Officer · Common Stock · 2026-07-06	Sell	10.25K	$447K	2026-07-06	2026-07-07
Fitzpatrick Jennifer Chief Legal Officer · Non-Qualified Stock Option (right to buy) · 2026-07-06	Exercise	10.25K	—	2026-07-06	2026-07-07
Resnick Joshua Director · Non-Qualified Stock Option (right to buy) · 2026-06-17	Grant	17.34K	—	2026-06-17	2026-06-18
Ruddy Marcella K. Director · Non-Qualified Stock Option (right to buy) · 2026-06-17	Grant	17.34K	—	2026-06-17	2026-06-18
Thompson Peter A. Director · Non-Qualified Stock Option (right to buy) · 2026-06-17	Grant	17.34K	—	2026-06-17	2026-06-18
Stelzer Laurie Director · Non-Qualified Stock Option (right to buy) · 2026-06-17	Grant	17.34K	—	2026-06-17	2026-06-18
Viney Joanne L. Director · Non-Qualified Stock Option (right to buy) · 2026-06-17	Grant	17.34K	—	2026-06-17	2026-06-18

SEC filings

EDGAR filings in SION · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.